AGG partner and Dietary Supplements industry team leader Kevin M. Bell was quoted in NutraIngredients on the patent viability of a certain heart drug in a clinical trial. To read the full article, please click here.
We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.